Envisage report cover

Global Migraine Drugs Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028

Published Date: Dec 2021

No. of Pages: 150

Status: Published

Report Code: EMR100999

Migraine Drugs Market is valued around USD 1851.23 Million in 2018 and expected to reach USD 2375.62 Million by 2025 with the CAGR of 3.37% over the forecast period. Increased prevalence of migraine and increased awareness among people are the key drivers for Global Migraine Drugs Market. Migraine Drugs market report published by the Envisage Market Research Pvt. Ltd. provides the detail information about migraine drugs market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with drug type, route of administration, distribution channel. Migraine is a neurological disorder which leads to severe headache coupled with nausea, vomiting and disturbed vision. It is most common in females as compared to males. Severe pain in head can be triggered by any means such as light, medicines, salty food, hormonal changes and others. In migraine, headache starts from one side of the head and slowly travels around the other side. There is no solitary cure for migraines. Treatment is aimed at preventing a full-blown attack, and alleviating the symptoms that occur. These symptoms are relieved by different drugs available in the market. Significant rise in prevalence of migraine around the world has augmented the growth of migraine drugs market. There are various factors driving the growth of the migraine drugs market, one of the major factors driving the growth of this market is increase in the prevalence of migraine. As per the Migraine Trust Organization report, Migraine is the third most common disease in the world with an estimated global prevalence of 14.7%. Furthermore, increased demand of better treatment and technological advancement led to the development of patches for the management of the migraine are expected to fuel the growth of migraine drugs market over the forecast period. Moreover, increasing awareness among people is also expected to support the growth of migraine drugs market. However, easy availability of generics, over the counter drugs and side effects associated with the migraine drugs are expected inhibit the growth of migraine drugs market over the forecast period.


Global Migraine Drugs Market Key Players:
AstraZeneca Plc.
Teva Pharmaceutical Industries Ltd.
Endo Pharmaceuticals Inc.
Alder Biopharmaceuticals Inc.
GlaxoSmithKline plc
Eli Lilly & Co.
Allergan Plc.
Novartis AG
Merck & Co., Inc.
Valeant Pharmaceutical International, Inc.
Eisai Co., Ltd.
Janssen Pharmaceutical Company
Pfizer, Inc.
Zosano Pharma Corporation
Avanir Pharmaceuticals, Inc. 


Migraine Drugs Market Segmentation:


By Drug Class


Abortive Medicine


Preventive Medicine



By Route of Administration


Oral


Injection


Others



By Distribution Channel


Hospital-based Pharmacies


Retail Pharmacies


Online Pharmacies


Other


By Region
North America - US, Mexico, Chile, Canada


Europe - UK, France, Germany, Italy


Asia Pacific - China, South Korea, Japan, India, Southeast Asia


Latin America - Brazil


Middle East and Africa - GCC, Africa, Rest of Middle East and Africa

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. Oral Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Migraine Drugs Market
Chapter 5. Global Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
5.1. Global Migraine Drugs Market Share, By Drug Class, 2015 - 2028 (USD Million)
5.1.1. Abortive Medicine
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Preventive Medicine
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
6.1. Global Migraine Drugs Market Share, By Route of Administration, 2015 - 2028 (USD Million)
6.1.1. Oral
6.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.2. Injection
6.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.3. Other
6.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 7. Global Migraine Drugs Market Overview, By Distribution Channel, 2015 - 2028(USD Million)
7.1. Global Migraine Drugs Market Share, By Distribution Channel, 2015 - 2028 (USD Million)
7.1.1. Hospital-based Pharmacies
7.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.2. Retail Pharmacies
7.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.3. Online Pharmacies
7.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.4. Other
7.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 8. Global Migraine Drugs Market Overview, By Geography, 2015 - 2028(USD Million)
8.1. Global Migraine Drugs Market Share, By Geography, 2015 - 2028(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2028 (%)
Chapter 9. North America Migraine Drugs Market Overview, By Countries, 2015 - 2028(USD Million)
9.1. North America Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.2. North America Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.3. North America Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.4. North America Migraine Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
9.1.5. North America Migraine Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
9.1.5.1. U.S. Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.1.2. U.S. Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.5.1.3. U.S. Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.2.2. Canada Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.5.2.3. Canada Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.3.2. Mexico Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.5.3.3. Mexico Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Migraine Drugs Market Overview, By Countries, 2015 - 2028(USD Million)
10.1. Europe Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
10.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.2. Europe Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
10.1.3. Europe Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
10.1.4. Europe Migraine Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.1.2. Germany Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.1.3. Germany Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.1.4. Other Segment
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.2.2. France Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.2.3. France Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.2.4. Other Segment
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.3.2. UK Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.3.3. UK Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.3.4. Other Segment
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.4.2. Italy Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.4.3. Italy Migraine Drugs Market Overview, By Route of Administration 2015 - 2028(USD Million)
10.1.5.4.4. Other Segment
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.5.2. Spain Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.5.3. Spain Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.5.4. Other Segment
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2028
10.1.5.6.2. Rest of Europe Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.6.3. Rest of Europe Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.6.4. Other Segment
Chapter 11. Asia Pacific Migraine Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1. Asia Pacific Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. Asia Pacific Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
11.1.3. Asia Pacific Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.4. Asia Pacific Migraine Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
11.1.5. Asia Pacific Migraine Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.1.2. India Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.1.3. India Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.1.4. Other Segment
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.2.2. China Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.2.3. China Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.2.4. Other Segment
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.3.2. Japan Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.3.3. Japan Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
11.1.5.3.4. Other Segment
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.4.2. South Korea Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.4.3. South Korea Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.4.4. Other Segment
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Migraine Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.5.3. Rest of Asia Pacific Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.5.4. Other Segment
Chapter 12. Middle East & Africa Migraine Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1. Middle East & Africa Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
12.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.2. Middle East & Africa Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.3. Middle East & Africa Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.4. Middle East & Africa Migraine Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
12.1.5. Middle East & Africa Migraine Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.1.2. GCC Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.5.1.3. GCC Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.1.4. Other Segment
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.2.2. South Africa Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.5.2.3. South Africa Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.2.4. Other Segment
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.3.4. Other Segment
Chapter 13. South America Migraine Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1. South America Migraine Drugs Market Overview, 2015 - 2028 (USD Million)
13.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.2. South America Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.3. South America Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.4. South America Migraine Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
13.1.5. South America Migraine Drugs Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.2. Brazil Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.6.3. Brazil Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.6.4. Other Segment
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.2. Argentina Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.7.3. Argentina Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.7.4. Other Segment
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2028
13.1.8.2. Rest of South America Migraine Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.8.3. Rest of South America Migraine Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.8.4. Other Segment
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. AstraZeneca Plc.
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Drug Class Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Teva Pharmaceutical Industries Ltd.
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Drug Class Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Endo Pharmaceuticals Inc.
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Drug Class Benchmarking
15.3.4. Recent initiatives
15.4. Alder Biopharmaceuticals Inc.
15.5. GlaxoSmithKline plc
15.6. Eli Lilly & Co.
15.7. Allergan Plc.
15.8. Others
Chapter 16. Migraine Drugs Market Cost Analysis
16.1. Migraine Drugs Market Key Offering Analysis
16.1.1. Key Offering
16.1.2. Price Trend of Key Drug Class
16.1.3. Key Suppliers
16.1.4. Labor Cost
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Migraine Drugs Market Industrial Chain Analysis
17.2. Upstream Offering Sourcing
17.3. Drug Class Sources of Migraine Drugs Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Drug Class Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Drug Class Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Migraine Drugs Market, 2015-2028 (USD Million)
4. Biochemical Sensor requirement, by country, 2015-2028 (USD Million)
5. North America Migraine Drugs Market, By Drug Class, 2015-2028 (USD Million)
6. North America Migraine Drugs Market, By Route of Administration, 2015-2028 (USD Million)
7. North America Migraine Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
8. Europe Migraine Drugs Market, By Drug Class, 2015-2028 (USD Million)
9. Europe Migraine Drugs Market, By Route of Administration, 2015-2028 (USD Million)
10. Europe Migraine Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
11. Asia Pacific Migraine Drugs Market, By Drug Class, 2015-2028 (USD Million)
12. Asia Pacific Migraine Drugs Market, By Route of Administration, 2015-2028 (USD Million)
13. Asia Pacific Migraine Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
14. Middle East & Africa Migraine Drugs Market, By Drug Class, 2015-2028 (USD Million)
15. Middle East & Africa Migraine Drugs Market, By Route of Administration, 2015-2028 (USD Million)
16. Middle East & Africa Migraine Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
17. South America Migraine Drugs Market, By Drug Class, 2015-2028 (USD Million)
18. South America Migraine Drugs Market, By Route of Administration, 2015-2028 (USD Million)
19. South America Migraine Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
20. Global Migraine Drugs Market, Company Market Share, 2020 - 2028 (%)
21. AstraZeneca Plc.: Drug Class Benchmarking
22. AstraZeneca Plc.: Financial Performance
23. Teva Pharmaceutical Industries Ltd.: Drug Class Benchmarking
24. Teva Pharmaceutical Industries Ltd.: Financial Performance
25. Endo Pharmaceuticals Inc.: Drug Class Benchmarking
26. Endo Pharmaceuticals Inc.: Financial Performance
27. Alder Biopharmaceuticals Inc.: Drug Class Benchmarking
28. Alder Biopharmaceuticals Inc.: Financial Performance
29. GlaxoSmithKline plc: Drug Class Benchmarking
30. GlaxoSmithKline plc: Financial Performance
31. Eli Lilly & Co.: Drug Class Benchmarking
32. Eli Lilly & Co.: Financial Performance

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Migraine Drugs Market share, By Drug Class, 2020 & 2028 (%)
10. Global Migraine Drugs Market share, by Abortive Medicine, By Drug Class, 2015 - 2028 (USD Million)
11. Global Migraine Drugs Market share, by Preventive Medicine, By Drug Class, 2015 - 2028 (USD Million)
12. Global Migraine Drugs Market share, By Route of Administration, 2020 & 2028 (%)
13. Global Migraine Drugs Market share, by Oral, By Route of Administration, 2015 - 2028 (USD Million)
14. Global Migraine Drugs Market share, by Injection, By Route of Administration, 2015 - 2028 (USD Million)
15. Global Migraine Drugs Market share, by Other, By Route of Administration, 2015 - 2028 (USD Million)
16. Global Migraine Drugs Market share, By Distribution Channel, 2020 & 2028 (%)
17. Global Migraine Drugs Market share, by Hospital-based Pharmacies, By Distribution Channel, 2015 - 2028 (USD Million)
18. Global Migraine Drugs Market share, by Retail Pharmacies, By Distribution Channel, 2015 - 2028 (USD Million)
19. Global Migraine Drugs Market share, by Online Pharmacies, By Distribution Channel, 2015 - 2028 (USD Million)
20. Global Migraine Drugs Market share, by Others, By Distribution Channel, 2015 - 2028 (USD Million)
21. Global Migraine Drugs Market share, by Region, 2020 & 2028 (%)
22. Global Migraine Drugs Market share, by Region, 2015 - 2028(USD Million)
23. North America Migraine Drugs Market, 2015 - 2028(USD Million)
24. North America Migraine Drugs Market share, by Countries, 2020 & 2028 (%)
25. U.S. Migraine Drugs Market, 2015 - 2028(USD Million)
26. Canada Migraine Drugs Market, 2015 - 2028(USD Million)
27. Mexico Migraine Drugs Market, 2015 - 2028(USD Million)
28. Europe Migraine Drugs Market, 2015 - 2028(USD Million)
29. Europe Migraine Drugs Market share, by Countries, 2020 & 2028 (%)
30. Spain Migraine Drugs Market, 2015 - 2028(USD Million)
31. UK Migraine Drugs Market, 2015 - 2028(USD Million)
32. Italy Migraine Drugs Market, 2015 - 2028(USD Million)
33. Germany Migraine Drugs Market, 2015 - 2028(USD Million)
34. France Migraine Drugs Market, 2015 - 2028(USD Million)
35. Rest of Europe Migraine Drugs Market, 2015 - 2028(USD Million)
36. Asia-Pacific Migraine Drugs Market, 2015 - 2028(USD Million)
37. Asia-Pacific Migraine Drugs Market share, by Countries, 2020 & 2028 (%)
38. China Migraine Drugs Market, 2015 - 2028(USD Million)
39. India Migraine Drugs Market, 2015 - 2028(USD Million)
40. Australia Migraine Drugs Market, 2015 - 2028(USD Million)
41. Japan Migraine Drugs Market, 2015 - 2028(USD Million)
42. Rest of Asia-Pacific Migraine Drugs Market, 2015 - 2028(USD Million)
43. Middle East & Africa Migraine Drugs Market, 2015 - 2028(USD Million)
44. Middle East & Africa Migraine Drugs Market share, by Countries, 2020 & 2028 (%)
45. GCC Migraine Drugs Market, 2015 - 2028(USD Million)
46. South Africa Migraine Drugs Market, 2015 - 2028(USD Million)
47. Rest Of Middle East & Africa Migraine Drugs Market, 2015 - 2028(USD Million)
48. South America Migraine Drugs Market, 2015 - 2028(USD Million)
49. Brazil Migraine Drugs Market, 2015 - 2028(USD Million)
50. Mexico Migraine Drugs Market, 2015 - 2028(USD Million)
51. Argentina Migraine Drugs Market, 2015 - 2028(USD Million)
52. Rest Of South America Migraine Drugs Market, 2015 - 2028(USD Million)

The Leading Key Players in Global Migraine Drugs Market